Drugs / PolyEnv1
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00623753 | May 2007 → Jan 2008 | HIV infectious disease | St. Jude Children's Research Hospital | Terminated | No outcome recorded |
| Phase 1 | NCT00187044 | Oct 1997 → Oct 2009 | HIV infectious disease | St. Jude Children's Research Hospital | Completed | No outcome recorded |
| Phase 1 | NCT00051922 | Oct 1997 → Jul 2006 | HIV infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PolyEnv1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00051922 ↗ |
| Modality | Vaccine | “Our new recombinant vaccine product is called PolyEnv1.” NCT00187044 ↗ |
| Route | Subcutaneous | “Subcutaneous administration of a recombinant vaccinia virus vaccine expressing multiple envelopes of HIV-1.” PMID 14735404 ↗ Jan 2004 |